Halsey, Endometriosis, and What Public Disclosure Really Means for Women's Health

Why Halsey's Endometriosis Disclosure Matters Beyond the Headlines

Halsey first spoke publicly about endometriosis in 2016, describing severe menstrual pain and the years of dismissal she experienced before receiving a diagnosis. Since then, she has discussed multiple miscarriages, fertility treatment, and the emotional weight of managing a chronic reproductive condition while maintaining a public career. That kind of transparency is rare and, for many women, validating in a way that clinical language rarely achieves.

Endometriosis affects approximately 190 million women and girls worldwide according to the World Health Organization. In the United States alone, the condition is associated with roughly $22 billion in annual direct and indirect costs, including lost productivity, repeated surgeries, and ongoing hormonal management. Despite those numbers, the average time from symptom onset to confirmed diagnosis remains 7 to 10 years in high-income countries, a delay driven partly by the normalization of menstrual pain and partly by structural gaps in women's health research.

When a widely followed public figure names the condition, describes the diagnostic odyssey, and refuses to minimize her experience, she shortens the mental runway between "this pain is normal" and "I should ask my doctor about endometriosis." That is not a small thing.

What Halsey Actually Disclosed and When

Halsey's health disclosures have been iterative rather than a single announcement. She discussed endometriosis and its effect on fertility in a 2016 Rolling Stone interview, described a miscarriage experienced on tour in 2015, and later confirmed additional pregnancy losses. In 2022, after the birth of her child Ender, she disclosed a constellation of diagnoses including lupus, Sjögren's syndrome, mast cell activation syndrome, and Ehlers-Danlos syndrome, conditions that frequently co-occur with endometriosis and share overlapping inflammatory mechanisms.

Each disclosure was made voluntarily, on her own timeline, and in her own words. That is the legal default for any patient.

The Clinical Picture She Described

Endometriosis involves endometrial-like tissue growing outside the uterus, most commonly on the ovaries, fallopian tubes, and peritoneum. The lesions respond to estrogen, bleeding cyclically and generating local inflammation, adhesions, and pain. Laparoscopic surgery remains the gold standard for definitive diagnosis, per ACOG Practice Bulletin No. 114, though imaging-based protocols are increasingly accepted for deep infiltrating disease.

Halsey's descriptions of severe dysmenorrhea, pelvic pain outside of menstruation, and difficulty sustaining pregnancies are textbook presentations of moderate-to-severe endometriosis. They are also descriptions that millions of women recognize and have been told to ignore.

Legal Framework: What Public Figures Owe the Public About Their Health

Nothing. Legally, a public figure owes the public nothing about her medical history.

This is a point worth making plainly, because the media coverage of celebrity health disclosures often implies a duty to share that does not exist in law. HIPAA, the Health Insurance Portability and Accountability Act, restricts how covered entities, meaning healthcare providers, insurers, and their business associates, may use or disclose protected health information. It does not restrict patients themselves from sharing or not sharing their own information.

A pop star, a politician, or any other public figure has the same medical privacy rights as any private citizen. The choice to disclose is entirely personal.

What Changes When You Are an Employee

For women who are not celebrities but who manage endometriosis in a workplace, the legal field is more complicated and more consequential.

The Americans with Disabilities Act (ADA). Severe endometriosis may qualify as a disability under the ADA if it substantially limits a major life activity, which the EEOC has confirmed can include reproductive functions, bladder and bowel function, and the ability to concentrate due to chronic pain. If your condition qualifies, you have the right to request reasonable accommodations without being required to disclose your full diagnosis. You can say "a chronic medical condition" and request flexible scheduling around flare days.

The Family and Medical Leave Act (FMLA). Employees at covered employers with at least 50 workers may take up to 12 weeks of unpaid, job-protected leave annually for a serious health condition. Endometriosis-related surgeries, hospitalizations, and chronic intermittent flares can all qualify as serious health conditions under the FMLA's regulatory definition, though you will need supporting documentation from a healthcare provider.

What you do not have to disclose. You do not have to tell your employer you have endometriosis. You do not have to disclose the specifics of your cycle, your fertility history, or your treatment plan. Your employer is entitled to functional information, meaning what you cannot do and for how long, not a clinical narrative.

Halsey's Disclosures as a Template for Autonomy

What Halsey modeled, whether intentionally or not, is a framework that any woman can adapt: disclose what serves you, when it serves you, on your own terms. She did not disclose her diagnosis to her record label before going public. She did not seek permission. She shared her story in contexts she controlled, interviews, social media, her own artistic work, and she named her conditions specifically rather than speaking in euphemism.

That specificity matters clinically. Vague references to "women's health issues" or "a reproductive condition" do not carry the same search and recognition weight as the word "endometriosis." When Halsey said the word on a major platform, she gave other women a term to bring to their own appointments.

The Diagnostic Delay Problem: A Legal and Clinical Failure

The 7-to-10-year average diagnostic delay for endometriosis is not just a clinical inconvenience. It represents a systemic failure with legal and policy dimensions.

A 2019 analysis published in BJOG found that women with endometriosis visited an average of 7 physicians before receiving a diagnosis. Delays were longer for women who presented primarily with bowel or bladder symptoms rather than pelvic pain, and for women whose pain was repeatedly attributed to irritable bowel syndrome or anxiety.

This pattern of dismissal has been documented across racial groups, but research consistently shows that Black women are less likely to receive a timely endometriosis diagnosis despite presenting with comparable or more severe symptoms, a disparity driven by provider bias, unequal access to specialty care, and the historical myth that Black women have higher pain tolerance. Halsey, who identifies as biracial, has not specifically addressed race-based diagnostic disparities in her public statements, but her visibility as a biracial woman with endometriosis challenges the outdated demographic profile of the "typical" endometriosis patient.

What the Delay Costs Women

Every year without treatment allows adhesions to progress, ovarian reserve to decline, and chronic pain pathways to become more entrenched. The American Society for Reproductive Medicine classifies endometriosis into four stages, with Stage III and IV associated with the highest rates of tubal distortion and infertility. A woman who spends a decade undiagnosed may present to a fertility specialist with disease that has already compromised her anatomy.

From a legal standpoint, diagnostic delay also raises questions of medical negligence, though these cases are difficult to litigate. Proving that a reasonable clinician should have pursued further investigation years earlier requires expert testimony and a documented pattern of symptom reporting that many women never received.

Documentation as Self-Protection

If you are currently in the diagnostic phase, the most protective thing you can do is create a paper trail. Keep a symptom diary with dates, pain scores, and functional impact. Send brief follow-up messages through your patient portal after appointments so your symptoms are documented in your own words. If a provider dismisses your concerns, request that their reasoning be noted in the visit summary.

This is not litigious thinking. It is the same documentation practice that any good clinician uses, and it gives future providers the longitudinal picture they need to act.

Endometriosis Across Life Stages: What Changes and When

Endometriosis is not a static disease. Its presentation, treatment options, and implications shift substantially depending on where you are in your reproductive life.

Reproductive Years (Teens Through Early 40s)

This is when most diagnoses occur, though diagnosis typically lags symptom onset by years. First-line medical management includes combined hormonal contraceptives used continuously to suppress ovulation and reduce cyclic bleeding. Progestin-only options including the levonorgestrel intrauterine device, norethindrone acetate, and the etonogestrel implant are also effective at reducing endometriosis-associated pain, and are often preferred for adolescents or women who cannot tolerate estrogen.

GnRH agonists like leuprolide acetate (Lupron) and GnRH antagonists like elagolix (Orilissa) are used for moderate-to-severe disease, but both classes induce a hypoestrogenic state associated with bone mineral density loss, typically limiting use to 6 to 24 months depending on the specific agent and whether add-back hormone therapy is prescribed concurrently.

Trying to Conceive

Endometriosis is responsible for 30 to 50 percent of female factor infertility cases. For women trying to conceive, the treatment approach changes substantially. Hormonal suppression is paused. Surgical excision of endometriomas greater than 4 centimeters is often recommended before IVF, though the evidence on whether surgery improves live birth rates is genuinely mixed. A 2020 Cochrane review found insufficient evidence to determine whether surgical removal of endometriomas before IVF improves outcomes, highlighting how much clinical uncertainty still surrounds this decision.

Halsey's public disclosures of multiple miscarriages are consistent with the elevated miscarriage risk associated with endometriosis, though attributing any individual pregnancy loss to endometriosis specifically requires careful clinical evaluation. Uterine anatomy, immune dysregulation, and endometrial receptivity are all areas of active research.

Perimenopause and Post-Menopause

Endometriosis does not always resolve at menopause. Residual lesions can be reactivated by exogenous estrogen, making menopausal hormone therapy decisions more complex for women with a history of the condition. The Menopause Society (formerly NAMS) recommends that women with endometriosis who use systemic estrogen for menopausal symptoms consider adding a progestogen or using a progestin-containing regimen, even after hysterectomy, to reduce the theoretical risk of stimulating residual disease.

Women who underwent hysterectomy without bilateral oophorectomy and who take estrogen-only therapy should discuss this history explicitly with their menopause clinician. This is a nuance that often gets lost when endometriosis is framed as a "young woman's disease."

Pregnancy, Fertility Treatment, and What Halsey's Story Reflects

Halsey's journey through pregnancy loss and eventually the birth of her child Ender in 2021 is clinically illustrative in ways that go beyond celebrity narrative.

Women with endometriosis face a higher prevalence of obstetric complications including preterm birth, placenta previa, and cesarean delivery, according to a large Swedish cohort study published in AJOG. These risks do not disappear once a pregnancy is established. Obstetric providers should be informed of an endometriosis diagnosis so monitoring can be appropriately intensified.

Fertility Treatment Considerations

For women who pursue IVF, the presence of endometriosis is associated with lower oocyte yield and, in some studies, reduced endometrial receptivity. ASRM guidelines note that the impact of endometriosis on IVF outcomes varies by stage and prior surgical history, and that women with Stage III or IV disease may benefit from longer gonadotropin stimulation protocols.

Egg freezing before disease progression is an option increasingly discussed in reproductive endocrinology clinics for younger women with newly diagnosed severe endometriosis, though data on outcomes in this specific population remain limited.

What Halsey's Disclosures Changed in Practice

Anecdotally, clinicians who work in reproductive medicine report increases in patients presenting with printed articles, social media posts, or specific questions prompted by celebrity disclosures. A 2021 analysis in the Journal of Women's Health found that celebrity health disclosures were associated with measurable increases in disease-related online searches and, in some cases, screening uptake. The Halsey effect, to the extent it can be quantified, likely contributed to more women entering their gynecology appointments with the word "endometriosis" already in their vocabulary.

Advocacy, Accuracy, and the Limits of Celebrity Health Narratives

Public health advocacy by celebrities carries real risk alongside real benefit. The benefit is reach: Halsey has tens of millions of followers across platforms, and a single post naming endometriosis reaches an audience that no academic paper or clinical guideline will ever touch.

The risk is simplification. Endometriosis is not one disease with one treatment. It ranges from minimal peritoneal implants to obliterative deep infiltrating disease invading the bowel, bladder, and diaphragm. Pain severity does not reliably correlate with disease stage. A woman with Stage I endometriosis may experience debilitating pain while a woman with Stage IV may have minimal symptoms. This heterogeneity means that no single celebrity narrative, however authentic, can represent the full spectrum of the condition.

What Halsey's advocacy does well: it names the condition, normalizes seeking care, challenges the "just bad periods" dismissal, and demonstrates that endometriosis affects women across racial and professional demographics. What it cannot do is substitute for individualized clinical assessment.

How to Use Celebrity Advocacy as a Clinical Starting Point

"I heard Halsey talk about endometriosis and my symptoms sound similar" is a completely legitimate way to begin a conversation with your gynecologist. You do not need a more sophisticated entry point than that. Use it to request a thorough menstrual history review, a physical exam, and if indicated, a transvaginal ultrasound to evaluate for endometriomas or adenomyosis.

If your provider dismisses your concerns based on a normal ultrasound alone, ask specifically about deep infiltrating endometriosis, which is frequently missed on standard imaging, and whether a referral to a specialist in minimally invasive gynecologic surgery is appropriate.

Who Should Pay Close Attention to Halsey's Story

You should give this more than passing attention if you identify with any of the following:

• You have had pelvic pain for more than 6 months that disrupts work, exercise, or daily function
• Your periods involve pain that requires you to miss school, work, or social obligations
• You have been told your pain is "just cramps" or attributed to anxiety without further investigation
• You have a first-degree relative with endometriosis, which increases your risk approximately 7-fold
• You are struggling to conceive after 6 months of trying (or 12 months if you are under 35 with no other identified risk factors)
• You are managing a co-occurring condition like lupus, Sjögren's syndrome, or Ehlers-Danlos syndrome, all of which have documented associations with endometriosis

Women who are postmenopausal and taking hormone therapy after a history of endometriosis should also revisit this topic with their prescribing clinician, particularly if they had a hysterectomy without removing both ovaries.

A Note on the Evidence Gap for Women of Color

Clinical trial enrollment for endometriosis studies has historically skewed toward white women of higher socioeconomic status. This means that treatment response data, surgical outcome data, and even diagnostic criteria have been validated primarily in a demographic subset that does not represent the full population of affected women. Black, Latina, and Asian women with endometriosis may have different symptom presentations, face different access barriers, and receive different clinical responses, but the data to characterize those differences precisely is thin.

Halsey has not published research. She has not run a clinical trial. But her willingness to be publicly identified as a biracial woman with endometriosis contributes, in a real if unmeasurable way, to expanding who clinicians picture when they consider the diagnosis.

That is not a small contribution. It is, however, not a substitute for the NIH mandate that clinical trials enroll representative populations and report outcomes stratified by race and ethnicity.